Form 4: Xtant Medical Holdings: Officer Reports Stock Award and Holdings

Mark A. Schallenberger, Chief Operations Officer of Xtant Medical Holdings, reports acquisition of restricted stock units and total holdings.

Summary

• On April 3, 2024, Mark A. Schallenberger, Chief Operations Officer of Xtant Medical Holdings, acquired 177,551 shares of common stock.
• These shares are in the form of restricted stock units (RSUs) that will vest over four years.
• Following the transaction, Schallenberger beneficially owns 382,695 shares of Xtant Medical Holdings common stock.
• This total includes shares issuable upon vesting of restricted stock unit awards granted under the company's equity incentive plans.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't contain information that would significantly sway investor sentiment positively or negatively.

Positives

• The vesting schedule of the restricted stock units incentivizes the COO to remain with the company for the long term.
• The increased share ownership aligns the COO's interests with those of the shareholders.

Risks

• The vesting of the RSUs is contingent upon Schallenberger's continued employment with Xtant Medical Holdings.
• If Schallenberger leaves the company before the vesting dates, he will forfeit the unvested shares.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's financial performance or future prospects, focusing instead on the reporting of stock ownership changes by an officer.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding the alignment of management's interests with shareholders' interests.

Stakeholder Impact

• Shareholders gain insight into the equity ownership of a key executive.
• Employees may view the stock award as a positive sign of the company's commitment to its leadership.

Key Dates